Our most recent study, "Hematology Analyzers & Reagents Market Forecast to 2027 - COVID-19 Impact and Global Analysis - by Product and Service, Application, End User, and Geography," predicts that the market will grow from US$ 7,252.54 million in 2019 to US$ 13,007.87 million in 2027, at a CAGR of 7.6%. The rising prevalence of hematologic illnesses and technological improvements in haematology analyzers are both responsible for the market growth for haematology analyzers and reagents. We anticipate major short- and mid-term effects from these drivers. The high cost of high-end systems, nevertheless, is anticipated to restrain the market's expansion for haematology analyzers and reagents.

Hematology products and services, hemostasis products and services, and immunohematology products and services make up the bulk of the market for haematology analyzers and reagents. The market for haematology analyzers and reagents, which is anticipated to grow during the projected period, is predicted to be dominated by haematological goods and services. The market for haematology analyzers and reagents is anticipated to be dominated by this sector, which is also projected to develop at the highest CAGR among the industry's product and service segments.

Get Sample Copy of Report PDF: https://www.theinsightpartners.com/sample/TIPRE00003261/

Hematology analyzers and reagents are employed in the diagnosis and treatment of a wide variety of disorders related to blood vessels, bone marrow, white blood cells, platelets, red blood cells, lymph nodes, and clotting factors. A haematology analyzer may use a variety of methods, including digital microscopy with artificial intelligence, electrical impedance, flow cytometry, and spectrophotometry. The morphology of the blood, its constituent parts, and the tissues that form blood are all analysed both qualitatively and quantitatively with the aid of haematology reagents. Slide stains, haematology analyzer reagents, haemoglobin testing reagents, and microscopy testing reagents are a few examples of the haematology reagents. Diluents, lysing agents, probe cleansers, and other substances may be among them.

Blood disorders can affect any region of the body, not just one specific area. Anemia, haemophilia, von Willebrand disease (VWD), and blood cancers like myeloma, leukaemia, and lymphoma are a few of the common blood diseases. Numerous blood disorders have a genetic component, and as these disorders become more common, the need for blood transfusions increases, driving up the price of haematology tools and reagents.

The need for haematology analyzers and reagents for diverse applications is also being driven by technical improvements in haematology analyzers. For instance, Beckman Coulter launched the DxH 690T haematology analyzer in the US in May 2020 in an effort to improve workflow and reduce downtime in medium-sized laboratories. The company also introduced the DxH 560 AL Hematology Analyzer (with Reagents) for medium-sized laboratories, which is the perfect tool to use with patients who are challenging to draw blood from (infants, patients with cancer, and the elderly) because it only requires a 17 microliter sample, which is one of the smallest aspiration volumes on the market. Additionally, compared to other analyzers in its class, the DxH 560 AL takes up around 30% less counter area.

Market for Hematology Analyzers and Reagents: Competitive Environment and Major Developments

Among the leading firms in the haematology analyzers & reagents market are Clinical Diagnostic Solutions, Inc., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Danaher, Bio-Rad Laboratories Inc., Abbott, Diatron, ERBA Diagnostics Inc., EKF Diagnostics, HORIBA Medical, and Biosystems SA. In order to keep up with changing consumer needs throughout the world, the firms utilise product innovation methods. This enables them to maintain their brand recognition in the global haematology analyzers & reagents market. In order to provide haematology analyzers & reagents for various studies, market players also form partnerships, collaborations, and contracts with hospitals, diagnostic centres, and academic & research organisations, which is fueling the growth of the haematology analyzers & reagents market.

Browse More Related Reports by the insight partners:

Generic Hematology Analyzers And Reagents Market

https://www.theinsightpartners.com/reports/generic-hematology-analyzers-and-reagents-market

Hematology Analyzers Market

https://www.theinsightpartners.com/reports/hematology-analyzers-market

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:

If you have any queries about this report or if you would like further information, please contact us:

Contact Person: Sameer Joshi

E-mail: sales@theinsightpartners.com

Phone: +1-646-491-9876